Differences between Newborn and Adult Mice in Their Response to Immune Thrombocytopenia [PDF]
Zhongbo Hu +5 more
openalex +1 more source
The Role of Chatbots in Enquiry‐Based Learning for Oral Health Students—An Exploratory Study
ABSTRACT Objective This study explores the reliability of four Chatbots in enquiry‐based learning. Four Chatbots, namely Microsoft Copilot, Google Gemini, ChatGPT 3.5 and Perplexity, were used to answer and generate questions in four specific subject areas.
Rohini Khareedi, Daniel Fernandez
wiley +1 more source
Immune thrombocytopenia in adolescents and young adults. [PDF]
Schifferli A.
europepmc +1 more source
The Clinicopathologic Spectrum of Rosai–Dorfman–Destombes Disease in Adults: An Analysis of 16 Cases
ABSTRACT Rosai–Dorfman–Destombes disease (RDD) is a rare histiocytic proliferation with protean clinical manifestations, resulting from the accumulation of activated histiocytes within nodal and extra‐nodal tissues. The diagnosis can be missed, particularly when biopsies are obtained from extra‐nodal sites, where histological features may be less ...
Mark Trinder +8 more
wiley +1 more source
Teclistamab-Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma. [PDF]
Quevedo-Salazar R +6 more
europepmc +1 more source
Autologous 111In‐labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry [PDF]
Ameet Sarpatwari +5 more
openalex +1 more source
ABSTRACT B‐cell maturation antigen (BCMA)‐directed chimeric antigen receptor (CAR) T‐cell therapies have revolutionized the approach and management of relapsed/refractory multiple myeloma (RRMM), and as of 2025, idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) are the only BCMA‐targeted CAR T‐cell therapies approved by the FDA.
Hector Garcia Pleitez +5 more
wiley +1 more source
Correction: A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia. [PDF]
Yamaguchi H +14 more
europepmc +1 more source
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?
ABSTRACT Mantle Cell Lymphoma (MCL) is an aggressive B‐cell non‐Hodgkin lymphoma characterized by the hallmark t(11;14)(q13;q32) translocation, resulting in cyclin D1 overexpression. Predominantly affecting elderly males, MCL exhibits marked clinical and biological heterogeneity, ranging from indolent SOX11‐negative variants to highly proliferative ...
Santino Caserta +10 more
wiley +1 more source

